Aim: To assess the effectiveness and clinical performance of early implant placement, 4–8 (Type 2) or 12–16 weeks (Type 3) after extraction, in single anterior sites. Methods: Studies reporting on Type 2 and Type 3 implant placement were identified. Findings were summarized in evidence tables. Main outcome was implant survival. Peri-implant soft and hard tissues changes, periodontal parameters, aesthetics and patient-reported outcomes were also evaluated. Quality of reporting of the included studies was evaluated through Consort, Newcastle–Ottawa scale and IHE quality appraisal checklist. Results: Nineteen eligible articles (seven from one RCT, three from two CCTs and nine from three case series) reporting on 140 patients and 140 implants were included. Type 3 implants showed comparable results to Type 4: 95% vs. 100% survival rates. Studies reported high values of implant survival, minimal technical and biological complications and high aesthetic scores in both short and long-term follow-ups for both Type 2 and Type 3 implant placement. Quality evaluation highlighted important weaknesses in the included trials. Conclusions: Limited data on Type 2 and Type 3 implant placement appear to indicate that they can perform well both short and long term. However, the limited number of cases, the significant heterogeneity of the included studies and the high risk of biases importantly reduce the generalizability of the findings. CRD42018117363.

Effectiveness and clinical performance of early implant placement for the replacement of single teeth in anterior areas: A systematic review

Graziani F.
Primo
;
2019-01-01

Abstract

Aim: To assess the effectiveness and clinical performance of early implant placement, 4–8 (Type 2) or 12–16 weeks (Type 3) after extraction, in single anterior sites. Methods: Studies reporting on Type 2 and Type 3 implant placement were identified. Findings were summarized in evidence tables. Main outcome was implant survival. Peri-implant soft and hard tissues changes, periodontal parameters, aesthetics and patient-reported outcomes were also evaluated. Quality of reporting of the included studies was evaluated through Consort, Newcastle–Ottawa scale and IHE quality appraisal checklist. Results: Nineteen eligible articles (seven from one RCT, three from two CCTs and nine from three case series) reporting on 140 patients and 140 implants were included. Type 3 implants showed comparable results to Type 4: 95% vs. 100% survival rates. Studies reported high values of implant survival, minimal technical and biological complications and high aesthetic scores in both short and long-term follow-ups for both Type 2 and Type 3 implant placement. Quality evaluation highlighted important weaknesses in the included trials. Conclusions: Limited data on Type 2 and Type 3 implant placement appear to indicate that they can perform well both short and long term. However, the limited number of cases, the significant heterogeneity of the included studies and the high risk of biases importantly reduce the generalizability of the findings. CRD42018117363.
2019
Graziani, F.; Chappuis, V.; Molina, A.; Lazarin, R.; Schmid, E.; Chen, S.; Salvi, G. E.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1029548
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 16
  • ???jsp.display-item.citation.isi??? 16
social impact